Subscribe To
Design therapeutics to present at the 2023 jefferies healthcare conference
CARLSBAD, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatme...
May 31, 2023, 6:30 am
Krystal clear: krystal biotech clears resistance in good volume
Last week, shares of the Pittsburgh-based genetic medicines developer surged more than 25% after the FD...
May 30, 2023, 7:36 am
Ultragenyx: a promising bet on rare genetic disorder therapies
Ultragenyx's pipeline boasts a diverse array of gene therapy candidates, including UX111, DTX401, DTX301, and UX701, offering transformative potential...
May 29, 2023, 7:15 am
Genetic testing services market anticipated to hit us$ 31.5 billion by 2031, expanding at a cagr of 8.4%: tmr report
The growing awareness about personalized medicines and the increased rate of genetic disorders across t...
May 26, 2023, 9:30 pm
23andme reports fy2023 fourth quarter and full year financial results
Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN F...
May 25, 2023, 8:05 pm
Myriad genetics (mygn) adds new test to oncology portfolio
Myriad Genetics (MYGN) expands Precise Oncology Solutions portfolio by adding a new biomarker test....
May 25, 2023, 1:32 pm
Goldman sachs maintains myriad genetics buy recommendation
Fintel reports that on May 24, 2023, Goldman Sachs maintained coverage of Myriad Genetics (NASDAQ:MYGN)...
May 24, 2023, 10:37 pm
Why shares of sarepta therapeutics are dropping wednesday
Sarepta focuses on gene therapies to treat rare diseases. SRP-9001 is designed to correct the genetic m...
May 24, 2023, 1:53 pm
Goldman sachs upgrades myriad genetics
Fintel reports that on May 23, 2023, Goldman Sachs upgraded their outlook for Myriad Genetics (NASDAQ:M...
May 23, 2023, 10:29 pm
Arbor biotechnologies to present at the stifel 2023 tailoring genes: genetic medicines day
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of...
May 23, 2023, 11:00 am
Verve therapeutics to participate in the stifel 2023 tailoring genes: virtual genetic medicines day
BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiova...
May 23, 2023, 10:30 am
Kalvista pharmaceuticals to present at stifel 2023 tailoring genes: genetic medicines day virtual conference
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
May 23, 2023, 6:30 am
Baylor genetics announces neuromuscular disorders panel
Latest Panel Analyzes 142 Genes Associated with Hereditary Neuromuscular Disorders HOUSTON, May 22, 2023 (GLOBE NEWSWIRE) — Baylor G...
May 22, 2023, 2:05 pm
Large investors slowed home purchases by late 2022
Large investors, who were buying homes and pricing out home buyers, are no longer investing in the housing market at a fr...
May 22, 2023, 1:50 pm
Krystal biotech stock rises after fda approves treatment for rare skin disease
Krystal Biotech Inc. KRYS, +5.49% shares rose Friday after the biotech drug company received Food and Drug Administration approval of a rare skin dise...
May 19, 2023, 2:39 pm
U.s. fda approves krystal biotech's skin disorder gene therapy
The U.S. Food and Drug Administration on Friday approved Krystal Biotech Inc's topical gene therapy for patients with a g...
May 19, 2023, 2:05 pm
Ultragenyx to present at the 2023 barclays – gene editing & gene therapy summit
NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...
May 19, 2023, 12:30 pm
Ultragenyx to present at the 2023 barclays - gene editing & gene therapy summit
NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
May 19, 2023, 8:30 am
14.7% cagr of gene panel market is estimated to account for usd 9,345 mn by the end of 2032 | market.us
The gene panel market refers to the industry involved in the development, manufacturing, and distribution of gene panels, which are diagnostic tools u...
May 18, 2023, 10:47 am
Prenetics global limited (pre) flat as market gains: what you should know
Prenetics Global Limited (PRE) closed the most recent trading day at $0.89, making no change from the p...
May 17, 2023, 6:55 pm